Cargando…
Translocation-Related Sarcomas
Chromosomal translocations are observed in approximately 20% of soft tissue sarcomas (STS). With the advances in pathological examination technology, the identification of translocations has enabled precise diagnoses and classifications of STS, and it has been suggested that the presence of and diff...
Autores principales: | Nakano, Kenji, Takahashi, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320865/ https://www.ncbi.nlm.nih.gov/pubmed/30487384 http://dx.doi.org/10.3390/ijms19123784 |
Ejemplares similares
-
Precision Medicine in Soft Tissue Sarcoma Treatment
por: Nakano, Kenji, et al.
Publicado: (2020) -
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
por: Takahashi, Mitsuru, et al.
Publicado: (2017) -
Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
por: Nakano, Kenji, et al.
Publicado: (2019) -
Challenges of Systemic Therapy Investigations for Bone Sarcomas
por: Nakano, Kenji
Publicado: (2022)